APIM Therapeutics apimtherapeutics.com


Public list: BIO 2016 (619) Pharma Startups (4732) Cancer Therapeutics (1137)

APIM Therapeutics is a biotechnology company dedicated to the development of anti-cancer agents targeting DNA repair and cell cycle control. APIM Therapeutics's pipeline of compounds includes a series of peptide drugs that target PCNA (Proliferating Cell Nuclear Antigen) and cell stress responses via APIM, a PCNA-interacting Stress Switch Peptide Motif identified in human AlkB homolog 2 (AlkB homolog 2 PCNA Interacting Motif). This motif is present in a large number of proteins involved in genom...Show all

APIM Therapeutics is a biotechnology company dedicated to the development of anti-cancer agents targeting DNA repair and cell cycle control. APIM Therapeutics's pipeline of compounds includes a series of peptide drugs that target PCNA (Proliferating ...Show all

Company (Alive / Active)

Phone:

Fax:

Sem Sælandsvei 14
Kjemiblokk 1, 3etg
N-7491
Norway

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
APIM Therapeutics $0M Oct 17, 2012

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related APIM Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Oligopeptidic compounds and uses thereof Sep 23, 2014 Jun 13, 2017 Patent
Oligopeptidic compounds and uses thereof Feb 20, 2009 Oct 28, 2014 Patent
Oligopeptidic compounds and uses thereof May 04, 2017 Application